If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
<br /> TREATMENT STRATEGIES<br /> DIABETES<br /> <br /> <br /> <br /> <br /> • β-cell Imaging<br /> • Diabetic Foot Treatment<br /> • Diabetes, Obesity and Cancer<br /> • Diabetes and Cardiovascular Risk<br /> • Diabetes and the Bone<br /> • Glucose Monitoring<br /> <br /> <br /> <br /> Articles include:<br /> Use of Continuous Glucose Monitoring in the Management of<br /> Subjects with Insulin-requiring Diabetes<br /> <br /> Testing with a Purpose: Making SMBG Worthwhile<br /> <br /> Aiming for Comprehensive Glycaemic Control in Type 2 Diabetes:<br /> The Emerging Role of Saxagliptin<br /> <br /> Recent Concepts in Bone Fractures and Type 2 Diabetes<br /> <br /> Effects of Omega-3-Acid Ethyl Esters on Macro- and<br /> Microvascular Function in Subjects
TREATMENT STRATEGIESDIABETES• β-cell Imagin
TREATMENT STRATEGIESDIABETES• β-cell Imagin
exploringDIABETES inspired to make aDIF
exploringDIABETES inspired to make aDIF
TREATMENT STRATEGIESDIABETESTreatment Strat
TREATMENT STRATEGIESDIABETESTreatment Strat
No more strips.Experience the testing revolution
No more strips.Experience the testing revolution
CONTENTS...91112313942
CONTENTS...91112313942
8083869195102106
8083869195102106
116125130143148
116125130143148
169176182185193197
169176182185193197
EDITORIALPANEL 2010including...Anne-Marie
EDITORIALPANEL 2010including...Anne-Marie
Treatment Strategies - ForewordForewordby
Treatment Strategies - ForewordForewordby
Treatment Strategies - Congress Review46th A
Treatment Strategies - Congress Review46th A
Treatment Strategies - Congress ReviewCartri
Treatment Strategies - Congress ReviewCartri
Treatment Strategies - Congress Review
Treatment Strategies - Congress Review
Treatment Strategies - Congress ReviewNation
Treatment Strategies - Congress ReviewNation
Treatment Strategies - Congress Reviewunmodi
Treatment Strategies - Congress Reviewunmodi
Treatment Strategies - Congress ReviewGenere
Treatment Strategies - Congress ReviewGenere
Treatment Strategies - Congress Reviewover t
Treatment Strategies - Congress Reviewover t
Treatment Strategies - Congress ReviewSquibb
Treatment Strategies - Congress ReviewSquibb
Treatment Strategies - Congress Reviewbuilt
Treatment Strategies - Congress Reviewbuilt
Treatment Strategies - Congress ReviewElectr
Treatment Strategies - Congress ReviewElectr
Treatment Strategies - Congress Reviewtype 2
Treatment Strategies - Congress Reviewtype 2
Treatment Strategies - Congress ReviewTestin
Treatment Strategies - Congress ReviewTestin
high glucose-variability groups. However, SMBG co
high glucose-variability groups. However, SMBG co
Treatment Strategies - Congress Reviewcombinat
Treatment Strategies - Congress Reviewcombinat
Patients were randomised into two groups: one wou
Patients were randomised into two groups: one wou
Treatment Strategies - Congress ReviewAiming
Treatment Strategies - Congress ReviewAiming
by HbA1c, and the incidence of micro- and macrova
by HbA1c, and the incidence of micro- and macrova
Treatment Strategies - Congress Reviewshowed
Treatment Strategies - Congress Reviewshowed
oral anti-hyperglycaemic drug for T2D for many ye
oral anti-hyperglycaemic drug for T2D for many ye
Treatment Strategies - Congress Reviewand tol
Treatment Strategies - Congress Reviewand tol
Treatment Strategies - β-cell ImagingIma
Treatment Strategies - β-cell ImagingIma
Treatment Strategies - β-cell ImagingKCI5
Treatment Strategies - β-cell ImagingKCI5
not alter the cell metabolism.31In this appr
not alter the cell metabolism.31In this appr
Treatment Strategies - β-cell Imagingcore gran
Treatment Strategies - β-cell Imagingcore gran
messenger; therefore measuring these movements an
messenger; therefore measuring these movements an
Treatment Strategies - β-cell Imagingkinetics
Treatment Strategies - β-cell Imagingkinetics
Treatment Strategies - β-cell ImagingImaging t
Treatment Strategies - β-cell ImagingImaging t
Treatment Strategies - β-cell Imaging47. Ban
Treatment Strategies - β-cell Imaging47. Ban
Treatment Strategies - Clinical ManagementU
Treatment Strategies - Clinical ManagementU
Treatment Strategies - Clinical Managementwil
Treatment Strategies - Clinical Managementwil
Treatment Strategies - Clinical Managementbas
Treatment Strategies - Clinical Managementbas
Treatment Strategies - Diabetes and Cardiovascula
Treatment Strategies - Diabetes and Cardiovascula
diabetes during the follow-up period were found t
diabetes during the follow-up period were found t
Treatment Strategies - Diabetes and Cardiovascula
Treatment Strategies - Diabetes and Cardiovascula
criteria were applied: the authors only considere
criteria were applied: the authors only considere
Treatment Strategies - Diabetes and Cardiovascula
Treatment Strategies - Diabetes and Cardiovascula
Treatment Strategies - Diabetes and Cardiovascula
Treatment Strategies - Diabetes and Cardiovascula
Treatment Strategies - Diabetes and Cardiovascula
Treatment Strategies - Diabetes and Cardiovascula
programmes might confer a different metabolic res
programmes might confer a different metabolic res
Treatment Strategies - Diabetes and Cardiovascula
Treatment Strategies - Diabetes and Cardiovascula
Treatment Strategies - Diabetes and the Bone
Treatment Strategies - Diabetes and the Bone
Treatment Strategies - Diabetes and the Boneo
Treatment Strategies - Diabetes and the Boneo
Treatment Strategies - Diabetes and the Bone
Treatment Strategies - Diabetes and the Bone
Treatment Strategies - Diabetes and the Boned
Treatment Strategies - Diabetes and the Boned
clear if the opposite is the case. In streptozoto
clear if the opposite is the case. In streptozoto
Treatment Strategies - Diabetes and the Boneb
Treatment Strategies - Diabetes and the Boneb
(95% CI: 2.2-21.6) after adjustment for age, BMI
(95% CI: 2.2-21.6) after adjustment for age, BMI
Treatment Strategies - Diabetes and the Bonen
Treatment Strategies - Diabetes and the Bonen
Treatment Strategies - Diabetes and the BoneRe
Treatment Strategies - Diabetes and the BoneRe
Treatment Strategies - Diabetes and the Bone
Treatment Strategies - Diabetes and the Bone
Treatment Strategies - Diabetes and the Brain
Treatment Strategies - Diabetes and the Brain
Treatment Strategies - Diabetes and the Brainp
Treatment Strategies - Diabetes and the Brainp
glycaemic control.41,42 Furthermore, in the ACCOR
glycaemic control.41,42 Furthermore, in the ACCOR
Treatment Strategies - Diabetes and the BrainT
Treatment Strategies - Diabetes and the BrainT
that a 10 mmHg reduction of mean systolic blood p
that a 10 mmHg reduction of mean systolic blood p
Treatment Strategies - Diabetes and the Brain
Treatment Strategies - Diabetes and the Brain
the use of aspirin is not sufficiently justified.
the use of aspirin is not sufficiently justified.
Treatment Strategies - Diabetes and the Braino
Treatment Strategies - Diabetes and the Braino
Treatment Strategies - Diabetes and the Brain
Treatment Strategies - Diabetes and the Brain
Treatment Strategies - Diabetes and the Brain
Treatment Strategies - Diabetes and the Brain
Treatment Strategies - Diabetes, Obesity and Canc
Treatment Strategies - Diabetes, Obesity and Canc
Treatment Strategies - Diabetes, Obesity and Canc
Treatment Strategies - Diabetes, Obesity and Canc
In addition, the inhibition of iNOS exerts insuli
In addition, the inhibition of iNOS exerts insuli
Treatment Strategies - Diabetes, Obesity and Canc
Treatment Strategies - Diabetes, Obesity and Canc
focus on each of the major pathological aspects o
focus on each of the major pathological aspects o
Treatment Strategies - Diabetes, Obesity and Canc
Treatment Strategies - Diabetes, Obesity and Canc
iNOSPPAR-γInflammatory/StressSignalling P
iNOSPPAR-γInflammatory/StressSignalling P
Treatment Strategies - Diabetes, Obesity and Canc
Treatment Strategies - Diabetes, Obesity and Canc
Treatment Strategies - Diabetes, Obesity and Canc
Treatment Strategies - Diabetes, Obesity and Canc
Treatment Strategies - Diabetes, Obesity and Canc
Treatment Strategies - Diabetes, Obesity and Canc
the spotlight onto the residual risk mentioned ab
the spotlight onto the residual risk mentioned ab
Treatment Strategies - Diabetes, Obesity and Canc
Treatment Strategies - Diabetes, Obesity and Canc
Treatment Strategies - Diabetic Foot Treatment
Treatment Strategies - Diabetic Foot Treatment
Treatment Strategies - Diabetic Foot Treatment
Treatment Strategies - Diabetic Foot Treatment
Treatment Strategies - Diabetic Foot Treatment
Treatment Strategies - Diabetic Foot Treatment
Treatment Strategies - Diabetic Foot Treatment
Treatment Strategies - Diabetic Foot Treatment
find a relative high number of cast induced lesio
find a relative high number of cast induced lesio
Treatment Strategies -Diabetic Foot Treatment
Treatment Strategies -Diabetic Foot Treatment
Treatment Strategies - Diabetic Foot Treatment
Treatment Strategies - Diabetic Foot Treatment
Treatment Strategies - Diabetic Foot Treatment
Treatment Strategies - Diabetic Foot Treatment
Treatment Strategies - Diabetic Neuropathy
Treatment Strategies - Diabetic Neuropathy
Treatment Strategies - Diabetic NeuropathyGrad
Treatment Strategies - Diabetic NeuropathyGrad
• Onset within 6 weeks• Asymme
• Onset within 6 weeks• Asymme
Treatment Strategies - Diabetic Neuropathycou
Treatment Strategies - Diabetic Neuropathycou
Treatment Strategies - Diabetic Neuropathy
Treatment Strategies - Diabetic Neuropathy
Treatment Strategies - Diabetic Neuropathyhyp
Treatment Strategies - Diabetic Neuropathyhyp
Treatment Strategies - Diabetic NeuropathyG
Treatment Strategies - Diabetic NeuropathyG
Treatment Strategies - Diabetic NeuropathyAG
Treatment Strategies - Diabetic NeuropathyAG
Treatment Strategies - Diabetic Neuropathyexpr
Treatment Strategies - Diabetic Neuropathyexpr
Treatment Strategies - Diabetic Neuropathyinh
Treatment Strategies - Diabetic Neuropathyinh
Treatment Strategies - Diabetic Neuropathyde
Treatment Strategies - Diabetic Neuropathyde
Treatment Strategies - Gene Therapy for Diabetes
Treatment Strategies - Gene Therapy for Diabetes
Treatment Strategies - Gene Therapy for Diabetes
Treatment Strategies - Gene Therapy for Diabetes
Treatment Strategies - Gene Therapy for Diabetes
Treatment Strategies - Gene Therapy for Diabetes
Treatment Strategies - Gene Therapy for Diabetes
Treatment Strategies - Gene Therapy for Diabetes
Treatment Strategies - Gene Therapy for Diabetes
Treatment Strategies - Gene Therapy for Diabetes
cells to ameliorate diabetes in T1D. Some of the
cells to ameliorate diabetes in T1D. Some of the
Treatment Strategies - Gene Therapy for Diabetes
Treatment Strategies - Gene Therapy for Diabetes
expression and reduced toxicity of the vector. Wi
expression and reduced toxicity of the vector. Wi
Treatment Strategies - Gene Therapy for Diabetes
Treatment Strategies - Gene Therapy for Diabetes
Treatment Strategies - Glucose Monitoring
Treatment Strategies - Glucose Monitoring
Treatment Strategies - Glucose Monitoringredu
Treatment Strategies - Glucose Monitoringredu
the USA through most commercial payers. According
the USA through most commercial payers. According
Treatment Strategies - Glucose Monitoring(81.3
Treatment Strategies - Glucose Monitoring(81.3
Treatment Strategies - Glucose Monitoringclini
Treatment Strategies - Glucose Monitoringclini
Treatment Strategies - Continuous Glucose Monitor
Treatment Strategies - Continuous Glucose Monitor
Treatment Strategies - Continuous Glucose Monitor
Treatment Strategies - Continuous Glucose Monitor
Treatment Strategies - Continuous Glucose Monitor
Treatment Strategies - Continuous Glucose Monitor
In other words, the LBGI is a non-negative quanti
In other words, the LBGI is a non-negative quanti
Treatment Strategies - Continuous Glucose Monitor
Treatment Strategies - Continuous Glucose Monitor
Treatment Strategies - Continuous Glucose Monitor
Treatment Strategies - Continuous Glucose Monitor
Treatment Strategies - Continuous Glucose Monitor
Treatment Strategies - Continuous Glucose Monitor
Treatment Strategies - Continuous Glucose Monitor
Treatment Strategies - Continuous Glucose Monitor
Treatment Strategies - Continuous Glucose Monitor
Treatment Strategies - Continuous Glucose Monitor
Treatment Strategies - Glucose MonitoringSu
Treatment Strategies - Glucose MonitoringSu
Treatment Strategies - Glucose Monitoringin t
Treatment Strategies - Glucose Monitoringin t
Studies on EfficacyThe evaluation of the impact
Studies on EfficacyThe evaluation of the impact
Treatment Strategies - Glucose Monitoring Sol
Treatment Strategies - Glucose Monitoring Sol
Treatment Strategies - Glucose MonitoringRefe
Treatment Strategies - Glucose MonitoringRefe
Treatment Strategies - Glucose Monitoring
Treatment Strategies - Glucose Monitoring
ACCORD, and almost no insulin use at enrolment. F
ACCORD, and almost no insulin use at enrolment. F
Treatment Strategies - Glucose Monitoringrenam
Treatment Strategies - Glucose Monitoringrenam
pancreatic β-cells, in a glucose-dependent and do
pancreatic β-cells, in a glucose-dependent and do
Treatment Strategies - Glucose Monitoringdete
Treatment Strategies - Glucose Monitoringdete
weeks were similar in both groups (1.9 versus 1.5
weeks were similar in both groups (1.9 versus 1.5
Treatment Strategies - Glucose Monitoringrece
Treatment Strategies - Glucose Monitoringrece
samples collected. From the results obtained the
samples collected. From the results obtained the
Treatment Strategies - Glucose MonitoringCompo
Treatment Strategies - Glucose MonitoringCompo
Treatment Strategies - Glucose MonitoringCompo
Treatment Strategies - Glucose MonitoringCompo
Treatment Strategies - Glucose Monitoringweigh
Treatment Strategies - Glucose Monitoringweigh
Treatment Strategies - Glucose MonitoringCre
Treatment Strategies - Glucose MonitoringCre
Treatment Strategies - Glucose Monitoringmel
Treatment Strategies - Glucose Monitoringmel
Treatment Strategies - Gut Micro-biotaDoe
Treatment Strategies - Gut Micro-biotaDoe
Treatment Strategies - Gut Micro-biotaamong f
Treatment Strategies - Gut Micro-biotaamong f
Treatment Strategies - Gut Micro-biotaAuthor
Treatment Strategies - Gut Micro-biotaAuthor
Treatment Strategies - Gut Micro-biotain turn
Treatment Strategies - Gut Micro-biotain turn
Treatment Strategies - Gut Micro-biotarequire
Treatment Strategies - Gut Micro-biotarequire
Treatment Strategies - Gynaecological Endocrinolo
Treatment Strategies - Gynaecological Endocrinolo
Treatment Strategies - Gynaecological Endocrinolo
Treatment Strategies - Gynaecological Endocrinolo
Treatment Strategies - Gynaecological Endocrinolo
Treatment Strategies - Gynaecological Endocrinolo
oestrogen receptor leading to a decrease in the b
oestrogen receptor leading to a decrease in the b
Treatment Strategies - Gynaecological Endocrinolo
Treatment Strategies - Gynaecological Endocrinolo
Treatment Strategies - Gynaecological Endocrinolo
Treatment Strategies - Gynaecological Endocrinolo
Treatment Strategies - Gynaecological Endocrinolo
Treatment Strategies - Gynaecological Endocrinolo
Treatment Strategies - Gynaecological Endocrinolo
Treatment Strategies - Gynaecological Endocrinolo
Treatment Strategies - Gynaecological Endocrinolo
Treatment Strategies - Gynaecological Endocrinolo
Treatment Strategies - Metabolic Pathways and Cou
Treatment Strategies - Metabolic Pathways and Cou
Treatment Strategies - Metabolic Pathways and Cou
Treatment Strategies - Metabolic Pathways and Cou
Treatment Strategies - Metabolic Pathways and Cou
Treatment Strategies - Metabolic Pathways and Cou
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - Management of New-onset Di
Treatment Strategies - Management of New-onset Di
Treatment Strategies - Management of New-onset Di
Treatment Strategies - Management of New-onset Di
Treatment Strategies - Management of New-onset Di
Treatment Strategies - Management of New-onset Di
Treatment Strategies - Management of New-onset Di
Treatment Strategies - Management of New-onset Di
Treatment Strategies - Management of New-onset Di
Treatment Strategies - Management of New-onset Di
Treatment Strategies - Management of New-onset Di
Treatment Strategies - Management of New-onset Di
Treatment Strategies - Management of New-onset Di
Treatment Strategies - Management of New-onset Di
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - New-onset Diabetes after T
Treatment Strategies - Patient and Public Involve
Treatment Strategies - Patient and Public Involve
Treatment Strategies - Patient and Public Involve
Treatment Strategies - Patient and Public Involve
Treatment Strategies - Patient and Public Involve
Treatment Strategies - Patient and Public Involve
Treatment Strategies - Patient Co-operation and E
Treatment Strategies - Patient Co-operation and E
Treatment Strategies - Patient Co-operation and E
Treatment Strategies - Patient Co-operation and E
Treatment Strategies - Patient Co-operation and E
Treatment Strategies - Patient Co-operation and E
Treatment Strategies - Patient Co-operation and E
Treatment Strategies - Patient Co-operation and E
Treatment Strategies - Patient Co-operation and E
Treatment Strategies - Patient Co-operation and E
Treatment Strategies - Patient Co-operation and E
Treatment Strategies - Patient Co-operation and E
Treatment Strategies - Patient Co-operation and E
Treatment Strategies - Patient Co-operation and E
Treatment Strategies - Patient Co-operation and E
Treatment Strategies - Patient Co-operation and E
Treatment Strategies - Patient Co-operation and E
Treatment Strategies - Patient Co-operation and E
Treatment Strategies - Patient Co-operation and E
Treatment Strategies - Patient Co-operation and E
Treatment Strategies - Patient Co-operation and E
Treatment Strategies - Patient Co-operation and E
Treatment Strategies - Patient Co-operation and E
Treatment Strategies - Patient Co-operation and E
Treatment Strategies - Therapeutic Strategies
Treatment Strategies - Therapeutic Strategies
Treatment Strategies - Therapeutic Strategies
Treatment Strategies - Therapeutic Strategies
Measurements were performed at 2mm depth withcon
Measurements were performed at 2mm depth withcon
Treatment Strategies - Therapeutic Strategies
Treatment Strategies - Therapeutic Strategies
interactions,9 thus reducing the formation of ROS
interactions,9 thus reducing the formation of ROS
Treatment Strategies - Therapeutic StrategiesR
Treatment Strategies - Therapeutic StrategiesR
Treatment Strategies - Towards Applied Genetics
Treatment Strategies - Towards Applied Genetics
Treatment Strategies - Towards Applied Genetics
Treatment Strategies - Towards Applied Genetics
successful conversion of insulin therapy to sulph
successful conversion of insulin therapy to sulph
Treatment Strategies - Towards Applied Genetics
Treatment Strategies - Towards Applied Genetics
Treatment Strategies - Towards Applied Genetics
Treatment Strategies - Towards Applied Genetics
TREATMENT STRATEGIES HEALTHCARE PUBLISHER
TREATMENT STRATEGIES HEALTHCARE PUBLISHER
Treatment Strategies - Vascular Function in Diabe
Treatment Strategies - Vascular Function in Diabe
Treatment Strategies - Vascular Function in Diabe
Treatment Strategies - Vascular Function in Diabe
consuming insulin-sensitive (or resistant) muscle
consuming insulin-sensitive (or resistant) muscle
Treatment Strategies - Vascular Function in Diabe
Treatment Strategies - Vascular Function in Diabe
Therefore, it appears that endothelial dysfunctio
Therefore, it appears that endothelial dysfunctio
Treatment Strategies - Vascular Function in Diabe
Treatment Strategies - Vascular Function in Diabe
et al. demonstrated that hyperglycaemia reduces t
et al. demonstrated that hyperglycaemia reduces t
Treatment Strategies - Vascular Function in Diabe
Treatment Strategies - Vascular Function in Diabe
extracellular matrix proteins (fibronectin, lamin
extracellular matrix proteins (fibronectin, lamin
Treatment Strategies - Vascular Function in Diabe
Treatment Strategies - Vascular Function in Diabe
modification by O-acetylglucosaminylation andpho
modification by O-acetylglucosaminylation andpho
Treatment Strategies - Vascular Function in Diabe
Treatment Strategies - Vascular Function in Diabe
production of reactive oxygen species (ROS). This
production of reactive oxygen species (ROS). This
Treatment Strategies - Vascular Function in Diabe
Treatment Strategies - Vascular Function in Diabe
Treatment Strategies - Vascular Function in Diabe
Treatment Strategies - Vascular Function in Diabe
Treatment Strategies - Vascular Function in Diabe
Treatment Strategies - Vascular Function in Diabe
Treatment Strategies - Vascular Function in Diabe
Treatment Strategies - Vascular Function in Diabe
Treatment Strategies - Events ListingsUpcomi
Treatment Strategies - Events ListingsUpcomi
TREATMENT STRATEGIESSERIES Visit th
TREATMENT STRATEGIESSERIES Visit th
For your patients with type 2 diabetes on monothe
For your patients with type 2 diabetes on monothe